TCT 278: Clinical Outcomes of Patients Who Experienced Loss of Pulse Pressure During Treatment With Impella for Acute Myocardial Infarction & Cardiogenic Shock

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Abiomed; Boston Scientific Corporation; Chiesi; Saranas; Zoll